GCP
CRL icon

GSA Capital Partners’s Charles River Laboratories CRL Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,310
Closed -$242K 1724
2024
Q4
$242K Buy
+1,310
New +$242K 0.02% 1324
2020
Q1
Sell
-16,572
Closed -$2.53M 1133
2019
Q4
$2.53M Sell
16,572
-2,451
-13% -$374K 0.29% 13
2019
Q3
$2.52M Buy
19,023
+6,297
+49% +$834K 0.34% 8
2019
Q2
$1.81M Sell
12,726
-3,774
-23% -$536K 0.2% 58
2019
Q1
$2.4M Buy
16,500
+659
+4% +$95.7K 0.24% 46
2018
Q4
$1.79M Buy
15,841
+3,564
+29% +$403K 0.21% 69
2018
Q3
$1.65M Sell
12,277
-5,974
-33% -$804K 0.09% 351
2018
Q2
$2.05M Sell
18,251
-14,503
-44% -$1.63M 0.1% 265
2018
Q1
$3.5M Buy
32,754
+823
+3% +$87.8K 0.18% 72
2017
Q4
$3.5M Buy
31,931
+8,747
+38% +$957K 0.21% 55
2017
Q3
$2.5M Buy
23,184
+10,544
+83% +$1.14M 0.17% 85
2017
Q2
$1.28M Sell
12,640
-21,766
-63% -$2.2M 0.08% 375
2017
Q1
$3.1M Sell
34,406
-13,485
-28% -$1.21M 0.17% 99
2016
Q4
$3.65M Sell
47,891
-2,770
-5% -$211K 0.22% 42
2016
Q3
$4.22M Sell
50,661
-5,485
-10% -$457K 0.23% 35
2016
Q2
$4.63M Buy
56,146
+1,467
+3% +$121K 0.26% 22
2016
Q1
$4.15M Sell
54,679
-4,682
-8% -$356K 0.26% 20
2015
Q4
$4.77M Buy
59,361
+1,209
+2% +$97.2K 0.23% 27
2015
Q3
$3.69M Sell
58,152
-30,126
-34% -$1.91M 0.18% 75
2015
Q2
$6.21M Buy
88,278
+42,523
+93% +$2.99M 0.24% 35
2015
Q1
$3.63M Buy
45,755
+2,842
+7% +$225K 0.14% 108
2014
Q4
$2.73M Buy
42,913
+15,447
+56% +$983K 0.19% 67
2014
Q3
$1.64M Sell
27,466
-13,531
-33% -$808K 0.09% 254
2014
Q2
$2.19M Buy
40,997
+20,667
+102% +$1.11M 0.1% 218
2014
Q1
$1.23M Sell
20,330
-7,178
-26% -$433K 0.09% 241
2013
Q4
$1.46M Sell
27,508
-12,486
-31% -$662K 0.12% 178
2013
Q3
$1.85M Buy
39,994
+18,601
+87% +$860K 0.15% 137
2013
Q2
$878K Buy
+21,393
New +$878K 0.1% 260